Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Ala Abu-Dogosh"'
Autor:
Ofer Kobo, Roi Efraim, Majdi Saada, Natalia Kofman, Ala Abu Dogosh, Yigal Abramowitz, Doron Aronson, Sa'ar Minha, Ariel Roguin, Simcha R Meisel
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0241149 (2020)
IntroductionEarly reports described decreased admissions for acute cardiovascular events during the SarsCoV-2 pandemic. We aimed to explore whether the lockdown enforced during the SARSCoV-2 pandemic in Israel impacted the characteristics of presenta
Externí odkaz:
https://doaj.org/article/aa2ede1d358a4a808afb262a3d46c1d3
Autor:
Gal Tsaban, Hilmi Alnsasra, Aref El Nasasra, Amjad Abu-Salman, Ala Abu-Dogosh, Itay Weissberg, Yael Ben-Baruch Golan, Orit Barrett, Roi Westreich, Enis Aboalhasan, Joseph Azuri, Ariel Hammerman, Ronen Arbel
Publikováno v:
American Journal of Cardiovascular Drugs. 22:677-683
Introduction: Secondary prevention of cardiovascular events among patients with diagnosed cardiovascular disease and high ischemic risk poses a significant challenge in clinical practice. The combinations of aspirin with low dose (LD) Ticagrelor or L
Autor:
Ala Abu Dogosh, Ahlam Adawi, Aref El Nasasra, Carlos Cafri, Orit Barrett, Gal Tsaban, Rami Barashi, Edward Koifman
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 18; Pages: 5299
Background: In recent years, trans-catheter aortic valve implantation (TAVI) has emerged as an excellent alternative to surgical aortic valve replacement (SAVR). Currently, there are several approved devices on the market, yet comparisons among them
Autor:
Hector M. Garcia Garcia, Molly B. Levine, Gebremedhin D. Melaku, Yirga Kahsay, Yair Feld, Amjad Abu Salman, Ariel Roguin, Carlos Cafri, Elias Hellou, Arthur Kerner, Ala Abu Dogosh, Rafael Beyar, Edward Koifman
Publikováno v:
JACC: Cardiovascular Interventions. 16:S29
Autor:
Gal Tsaban, Hilmi Alnsasra, Ala Abu-Dogosh, Itai Weissberg, Yael Ben-Baruch Golan, Orit Barrett, Roi Westreich, Enis Aboalhasan, Ariel Hammerman, Joseph Azuri, Ronen Arbel
Publikováno v:
Circulation. 144
Introduction: Secondary prevention of cardiovascular events among patients with diagnosed cardiovascular disease and high ischemic risk poses a significant challenge in clinical practice. Both Ticagrelor and low-dose (LD) Rivaroxaban have shown super
Autor:
Gal Tsaban, Hilmi Alnsasra, Ala Abu-Dogosh, Itai Weissberg, Yael Golan, Orit Barrett, Roi Westreich, Enis Aboalhasan, Joseph Azuri, Ariel Hammerman, Ronen Arbel
Publikováno v:
Circulation. 144
Introduction: Heart failure with preserved ejection fraction (HFpEF) is associated with frequent hospitalizations and an increased risk of death. There are no therapies with certain benefits for the treatment of HFpEF. Spironolactone and Sacubitril/V
Autor:
Yair Feld, Amjad Abu Salman, Ariel Roguin, Rafael Beyar, Carlos Cafri, Ala Abu Dogosh, Yirga Kahsay, Molly Levine, Gebremedhin Melaku, Hector Garcia-Garcia
Publikováno v:
Cardiovascular Revascularization Medicine. 40:47
Autor:
Yigal Abramowitz, Ala Abu Dogosh, Doron Aronson, Natalia Kofman, Roi Efraim, Ariel Roguin, Ofer Kobo, Sa'ar Minha, Simcha R. Meisel, Majdi Saada
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0241149 (2020)
PLoS ONE
PLoS ONE
Funding Acknowledgements Type of funding sources: None. We aimed to explore whether the lockdown enforced during the SARSCoV-2 pandemic in Israel impacted the characteristics of presentation, reperfusion times, and early outcomes of ST-elevation myoc
Autor:
Miri Merkin, Gabriel Rosenstein, Lital Hadad, Orit Barrett, Hector M. Garcia-Garcia, Aref El Nasasra, Yigal Abramowitz, Carlos Cafri, Romain Didier, Edward Koifman, Doron Zahger, Ala Abu Dogosh
Publikováno v:
Archives of Medical Science.
IntroductionIntervention on coronary bifurcations lesions (CBL) is challenging. While provisional side branch (PS) stenting is the recommended method in most cases, there is no consensus on the preferred 2-stent technique.Material and methodsWe perfo
Publikováno v:
Journal of Cardiology Case Reports. 4